These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 21357586)
1. Empirical treatment of influenza-associated pneumonia in primary care: a descriptive study of the antimicrobial susceptibility of lower respiratory tract bacteria (England, Wales and Northern Ireland, January 2007-March 2010). Blackburn RM; Henderson KL; Lillie M; Sheridan E; George RC; Deas AH; Johnson AP Thorax; 2011 May; 66(5):389-95. PubMed ID: 21357586 [TBL] [Abstract][Full Text] [Related]
2. [Amoxicillin/clavulanic acid (875/125 mg). New pharmacodynamic aspects]. Lode H Dtsch Med Wochenschr; 1999 Dec; 124(48):1459-61. PubMed ID: 10615328 [No Abstract] [Full Text] [Related]
3. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials. Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of cerebrospinal isolates from patients with meningitis. Liskova A; Benca J; Kalavsky E; Kovac M; Rudinsky B; Ondrusova A; Kiwou M Neuro Endocrinol Lett; 2007 Nov; 28 Suppl 3():5-6. PubMed ID: 18030262 [TBL] [Abstract][Full Text] [Related]
5. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy]. Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256 [TBL] [Abstract][Full Text] [Related]
6. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study). Jacobs E; Dalhoff A; Korfmann G Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763 [TBL] [Abstract][Full Text] [Related]
8. [Antibiotic resistance of S. pneumoniae and H. influenzae strains isolated from patients with community acquired respiratory tract infections. BACTRO multicenter, multidisciplinary study]. Tudose C; Bumbăcea D; Bogdan M; Pneumologia; 2011; 60(1):30-5. PubMed ID: 21548198 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain. Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733 [TBL] [Abstract][Full Text] [Related]
10. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000]. Melo-Cristino J; Fernandes ML; Serrano N; Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155 [TBL] [Abstract][Full Text] [Related]
11. The use of pharmacokinetic/pharmacodynamic principles to predict clinical outcome in paediatric acute otitis media. Dagan R Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S127-30. PubMed ID: 17980558 [TBL] [Abstract][Full Text] [Related]
12. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. II. Clinical studies]. Nikodemowicz E; Owsiński J; Przybyłkiewicz Z; Kasprowicz A; Maternowska W; Kamińska M; Walaszek K; Prus F Pneumonol Pol; 1980 Aug; 48(8):545-22. PubMed ID: 6968434 [No Abstract] [Full Text] [Related]
14. Bacterial aetiology and outcome in children with severe pneumonia in Uganda. Nantanda R; Hildenwall H; Peterson S; Kaddu-Mulindwa D; Kalyesubula I; Tumwine JK Ann Trop Paediatr; 2008 Dec; 28(4):253-60. PubMed ID: 19021940 [TBL] [Abstract][Full Text] [Related]
15. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Madhi SA; Petersen K; Madhi A; Khoosal M; Klugman KP Clin Infect Dis; 2000 Jul; 31(1):170-6. PubMed ID: 10913417 [TBL] [Abstract][Full Text] [Related]
16. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae. Jones RN; Sader HS; Stilwell MG; Fritsche TR Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904 [TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000. Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258 [TBL] [Abstract][Full Text] [Related]
18. Alarmingly decreasing rates of amoxicillin-clavulanate susceptibility among clinical isolates of Haemophilus influenzae from 2001 to 2009 in a medical center in Taiwan. Chung KP; Huang YT; Lee LN; Yu CJ; Lai CC; Hsueh PR J Infect; 2011 Feb; 62(2):185-7. PubMed ID: 21145354 [No Abstract] [Full Text] [Related]
19. Antimicrobial susceptibility patterns of Haemophilus influenzae and Streptococcus pneumoniae isolates in a Beirut general university hospital between 2000 and 2004. Daoud Z; Cocozaki A; Hakime N Clin Microbiol Infect; 2006 Jan; 12(1):86-90. PubMed ID: 16460553 [TBL] [Abstract][Full Text] [Related]
20. Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents. Pottumarthy S; Fritsche TR; Sader HS; Stilwell MG; Jones RN Int J Antimicrob Agents; 2005 Apr; 25(4):282-9. PubMed ID: 15784306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]